Friedl-Naderer Johanna's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Jun 17, 2026
- Accession no.
- 0001915598-26-000002
- Filed
- Jun 17, 2026
- Trade date
- Jun 16, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $2.66K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Friedl-Naderer JohannaCIK 0001915598 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | SSaleDisposed | −145 | $18.33 | −$2,657.85 | 154,208 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.